---
$id: https://graph.org.ai/products/commodity/51282953
$type: Product
source: UNSPSC
code: "51282953"
title: "Enoxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enoxacin

**UNSPSC Code**: 51282953
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-infective agent with the molecular formula C15H17FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325OGW249P, chemically known as 1,8-naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl but more generally known as enoxacin, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules Enoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06540MIG. The term ENOXACIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 40, No. 6, 1986, List 26). The World Health Organization schedules enoxacin in its Anatomical Therapeutic Chemical (ATC) Classification. ENOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: FC1C(N2CCNCC2)NC2N(CC)CC(C(=O)C2C1)C(=O)O.

